In particular, IDH mutations represent the most important independent prognostic factor associated with a favorable outcome among adult diffuse gliomas, as IDH-mutant adult astrocytomas have a relatively better prognosis in terms of disease-free survival and overall survival than their IDH wild-type counterparts. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).